Complete Genome Sequence of the Ebosin-Producing Strain Streptomyces sp. 139

Limei Ai; Mengxin Geng; Ming Ma; Liping Bai

doi:10.1128/MRA.01283-19

Complete Genome Sequence of the Ebosin-Producing Strain Streptomyces sp. 139

Microbiol Resour Announc. 2019 Dec 5;8(49):e01283-19. doi: 10.1128/MRA.01283-19.

Authors

Limei Ai¹, Mengxin Geng¹, Ming Ma¹, Liping Bai^{2

3}

Affiliations

¹ NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
² NHC Key Laboratory of Biotechnology of Antibiotics, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China lipingbai1973@163.com.
³ CAMS Key Laboratory of Synthetic Biology for Drug Innovation, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Abstract

Members of the genus Streptomyces are known for their ability to produce compounds with various bioactivities and for their complex morphologies. Streptomyces sp. strain 139 is the producer strain of the exopolysaccharide (EPS) ebosin, which has remarkable in vivo antirheumatic arthritis activity. Here, we report its complete genome sequence, which will facilitate the study of the biosynthesis of ebosin.